Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

Gilead Sciences CEO Daniel O'Day joins 'Squawk Box' to discuss Gilead's drug pipeline in 2024, the company's HIV treatment, breast cancer drug, and more.